With all the twists and turns coming from the U.S. federal government, decriminalization and legalization of psychedelics advancing all across the country,...
The article 2022 End of Year Review: Cybin was originally published on Microdose. The end of the year is a convenient time to look back and...
Also a peek at their plans for the year ahead. The post How 5 Psychedelics Companies Fared in 2022 appeared first on Green Market Report.
TORONTO, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug...
TORONTO, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”) today issued...
Pharmaceutical Grade Psilocybin Synthesized By Mindset’s Patent Pending ProcessTORONTO, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE:...
Cybin Inc. (NEO:CYBN) (NYSE American:CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, today reported unaudited...
5th Annual Neuropsychiatric & Psychedelics Drug Development Summit in Boston, MA on October 31st Neuroscience 2022 by the Society of Neuroscience...
The article News You Might Have Missed: Oct 11th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
Cybin Inc. (NEO:CYBN | NYSE AMERICAN:CYBN)), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, is pleased to provide...